In the Lab Elizabeth Cooney STAT Plus: New findings about little-studied cellular compartments could help make chemo more effective
Health Elizabeth Cooney STAT Plus: Recapping ASCO 2020, talking cancer therapy combinations, and looking to the future
In the Lab Sharon Begley Our body systems age at different rates, study finds, pointing to personalized care to extend healthy life
Health Tech Casey Ross How an AI expert took on his toughest project ever: writing code to save his son’s life
In the Lab Sharon Begley Buffalo gave us spicy wings and the ‘book of life.’ Here’s why that’s undermining personalized medicine
First Opinion Michael J. Joyner and Nigel Paneth Precision medicine’s rosy predictions haven’t come true. We need fewer promises and more debate
Health Elizabeth Cooney STAT Plus: ‘We shouldn’t leave anybody behind’: Inequities in cancer genomics undercut promise of precision medicine
Biotech Elizabeth Cooney STAT Plus: Foundation Medicine wins FDA approval for liquid biopsy able to detect mutations in multiple cancers
Biotech Matthew Herper STAT Plus: Turning Point releases positive data for targeted cancer drug, points to more rapid FDA filing
Health Elizabeth Cooney Deaths from the most common lung cancer are falling fast, hinting at the impact of improved treatment
Biotech Elizabeth Cooney STAT Plus: Startup Spotlight: Aiming to speed precision cancer therapies to children
First Opinion David A. Pearce We need better regulation of stem cell therapies, especially rogue clinics
In the Lab Karen Weintraub Growing tumors in a dish, scientists try to personalize pancreatic cancer treatment
First Opinion Edward Abrahams Personalized treatments may be threatened by drug cost-containment proposals
Health Rebecca Robbins, Adam Feuerstein and Damian Garde STAT Plus: He went hunting for gold-standard research on artificial intelligence in medicine — and didn’t find much
First Opinion Harris A. Gelbard Multi-target drugs should be in the pharma pipeline along with precision drugs
Business Rebecca Robbins With human drugs, a Silicon Valley startup hopes to deliver precision medicine to dogs
First Opinion Lee D. Cooper Genetic testing plus IVF can sidestep genetic disease and reduce the need for high-priced therapies
Biotech Jonathan Saltzman — Boston Globe STAT Plus: For one cancer patient, biotech’s genetic test turns out to be a ‘lifesaver’
Health Liz Szabo — Kaiser Health News Pricey precision medicine often financially toxic for cancer patients
First Opinion Richard G. Hamermesh and Kathy E. Giusti Precision medicine needs a business mindset in order to flourish
First Opinion Franklin W. Maddux Kidney disease is a killer. More precise classification can help tame it
First Opinion Akbar K. Waljee, Sameer D. Saini and Brahmajee K. Nallamothu Doctors could prescribe drugs more accurately — if they could get the data